Annexon (ANNX) Deferred Taxes (2019 - 2021)

Annexon (ANNX) posted quarterly Deferred Taxes of -$93000.0 for Q1 2021, down 5.68% year-over-year from -$98602.4 in Q1 2020, and up 2.11% quarter-over-quarter from -$95000.0 in Q4 2020.

Annexon (ANNX) Deferred Taxes (2019 - 2021) Analysis & Trends

Annexon's Deferred Taxes history runs 3 years deep, the most recent figure standing at -$93000.0 for Q1 2021.

  • In Q1 2021, Deferred Taxes fell 5.68% year-over-year to -$93000.0; the TTM figure through Mar 2021 stood at -$371000.0 (changed N/A YoY), while the FY2020 annual figure was -$366000.0, down 7.02% from the prior year.
  • Deferred Taxes for Q1 2021 stood at -$93000.0, up from -$95000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was -$88000.0 in Q3 2019, with the low at -$95000.0 in Q4 2020.
  • The 3-year median for Deferred Taxes is -$90000.0 (2020), against an average of -$90714.3.
  • Peak annual rise in Deferred Taxes reached 5.68% in 2020, while the deepest fall reached 7.95% in 2020.
  • Annexon's Deferred Taxes stood at -$88000.0 in 2019, then fell by 7.95% to -$95000.0 in 2020, then advanced by 2.11% to -$93000.0 in 2021.
  • Business Quant data shows ANNX's Deferred Taxes at -$93000.0 in Q1 2021, -$95000.0 in Q4 2020, and -$93000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Annexon 1.00 Bn 1.00 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 -93,000.00
Dec 31, 2020 -95,000.00
Sep 30, 2020 -93,000.00
Jun 30, 2020 -90,000.00
Mar 31, 2020 -88,000.00
Dec 31, 2019 -88,000.00
Sep 30, 2019 -88,000.00